Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amn Healthcare Services (AMN) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Amn Healthcare Services (AMN) over the last 17 years, with Q3 2025 value amounting to $52.6 million.

  • Amn Healthcare Services' Cash & Equivalents rose 7229.46% to $52.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.6 million, marking a year-over-year increase of 7229.46%. This contributed to the annual value of $10.6 million for FY2024, which is 6766.66% down from last year.
  • Latest data reveals that Amn Healthcare Services reported Cash & Equivalents of $52.6 million as of Q3 2025, which was up 7229.46% from $41.5 million recorded in Q2 2025.
  • Amn Healthcare Services' 5-year Cash & Equivalents high stood at $180.9 million for Q4 2021, and its period low was $7.0 million during Q2 2023.
  • Over the past 5 years, Amn Healthcare Services' median Cash & Equivalents value was $52.6 million (recorded in 2025), while the average stood at $70.3 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first crashed by 9116.27% in 2023, then skyrocketed by 58498.5% in 2024.
  • Amn Healthcare Services' Cash & Equivalents (Quarter) stood at $180.9 million in 2021, then tumbled by 64.34% to $64.5 million in 2022, then tumbled by 48.96% to $32.9 million in 2023, then plummeted by 67.67% to $10.6 million in 2024, then soared by 394.28% to $52.6 million in 2025.
  • Its Cash & Equivalents stands at $52.6 million for Q3 2025, versus $41.5 million for Q2 2025 and $55.8 million for Q1 2025.